Microbiological Pathology

Medicine & Life Sciences

1. South Africa 100%
2. HIV 44%
3. AIDS Vaccines 44%
4. Vaccines 31%
5. HIV-1 21%
6. HIV Infections 19%
7. Placebos 14%
8. Immunization 13%
9. Candidemia 13%
10. Vaccination 12%
11. Acinetobacter baumannii 12%
12. Multidrug-Resistant Tuberculosis 12%
13. Risk-Taking 11%
14. Hepatitis B virus 9%
15. ceftaroline fosamil 9%
16. Namibia 9%
17. Tertiary Care Centers 8%
18. Genes 8%
19. Safety 8%
20. Pregnancy 8%
21. Pregnant Women 8%
22. Polymerase Chain Reaction 7%
23. Serogroup 7%
24. Mycoplasma genitalium 7%
25. Papillomavirus Vaccines 7%
26. Fluconazole 7%
27. Laboratory Infection 7%
28. Incidence 7%
29. Foams and Jellies Vaginal Creams 7%
30. Viral Load 7%
31. Genotype 7%
32. Mycoplasma Infections 7%
33. Fungemia 7%
34. Infections 7%
35. Sentinel Surveillance 7%
36. Tenofovir 7%
37. Disease Outbreaks 7%
38. Uganda 6%
39. vpu Genes 6%
40. Sexual Health 6%
41. Kenya 6%
42. Edible Plants 6%
43. Immunization Programs 6%
44. Urethritis 6%
45. Candida parapsilosis 6%
46. Whole Genome Sequencing 6%
47. Coinfection 6%
48. Candida 6%
49. Sexually Transmitted Diseases 6%
50. Multiple Drug Resistance 6%
51. Eswatini 6%
52. Population 6%
53. Streptococcus 6%
54. Streptococcus agalactiae 6%
55. Salmonella enterica 6%
56. Trans-Activators 6%
57. Phase II Clinical Trials 6%
58. Genetic Variation 6%
59. Molecular Epidemiology 5%
60. Ceftriaxone 5%
61. Adenoviridae 5%
62. Child 5%
63. Reproductive Health Services 5%
64. Clinical Trials 5%
65. Highly Active Antiretroviral Therapy 5%
66. Mutation 5%
67. Delayed Diagnosis 5%
68. Randomized Controlled Trials 5%
69. Microsatellite Repeats 5%
70. Health 5%
71. Sexual and Gender Minorities 5%
72. Occupational Groups 5%
73. Sexual Behavior 5%
74. Tuberculosis 5%
75. Neutropenia 5%
76. Neutralizing Antibodies 5%